CST6 suppresses osteolytic bone disease in multiple myeloma by blocking osteoclast differentiation
Osteolytic bone disease is a hallmark of multiple myeloma (MM). A significant fraction (~20%) of MM patients do not develop osteolytic lesions (OLs). The molecular basis for the absence of bone disease in MM is not understood. We combined PET-CT and gene expression profiling (GEP) of purified BM CD1...
Những tác giả chính: | Dongzheng Gai, Jin-Ran Chen, James P. Stewart, Intawat Nookaew, Hasem Habelhah, Cody Ashby, Fumou Sun, Yan Cheng, Can Li, Hongwei Xu, Bailu Peng, Tarun K. Garg, Carolina Schinke, Sharmilan Thanendrarajan, Maurizio Zangari, Fangping Chen, Bart Barlogie, Frits van Rhee, Guido Tricot, John D. Shaughnessy Jr., Fenghuang Zhan |
---|---|
Định dạng: | Bài viết |
Ngôn ngữ: | English |
Được phát hành: |
American Society for Clinical Investigation
2022-09-01
|
Loạt: | The Journal of Clinical Investigation |
Những chủ đề: | |
Truy cập trực tuyến: | https://doi.org/10.1172/JCI159527 |
Những quyển sách tương tự
-
Bispecific BCMA/CD24 CAR-T cells control multiple myeloma growth
Bằng: Fumou Sun, et al.
Được phát hành: (2024-01-01) -
Prognostic value of ferritin in ASCT MM patients: integration with GEP models and ISS series systems
Bằng: Wancheng Guo, et al.
Được phát hành: (2024-02-01) -
Multi-omics reveal immune microenvironment alterations in multiple myeloma and its precursor stages
Bằng: Yan Cheng, et al.
Được phát hành: (2024-11-01) -
Ethnic Disparities in AL Amyloidosis Outcomes Among Hospitalized Patients in the United States
Bằng: Samer Al Hadidi, et al.
Được phát hành: (2022-07-01) -
B‐cell maturation antigen‐based therapies post‐talquetamab in relapsed or refractory multiple myeloma
Bằng: Asis Shrestha, et al.
Được phát hành: (2024-06-01)